FDA Requires Labeling Changes for Some Cough and Cold Drugs to Better Protect Children
By Zachary Brennan -
Published 11 January 2018
The US Food and Drug Administration (FDA) on Thursday announced safety labeling changes for prescription cough and cold medicines containing codeine or hydrocodone as the risks of these medicines outweigh their benefits in children younger than 18.
Categories: News, US, FDA, Compliance, Crisis management, Drugs, Labeling
Tags: codeine, cough and cold, hydrocodone